- Home
- Publications
- Publication Search
- Publication Details
Title
Optimal Management of Brain Metastases from Breast Cancer
Authors
Keywords
Overall Survival, Bevacizumab, Trastuzumab, Brain Metastasis, Capecitabine
Journal
CNS DRUGS
Volume 27, Issue 2, Pages 121-134
Publisher
Springer Nature
Online
2012-12-18
DOI
10.1007/s40263-012-0024-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I study of lapatinib (L) in combination with whole-brain radiation therapy (WBRT) in patients (pts) with brain metastases from HER2-positive breast cancer.
- (2017) N. U. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- LANDSCAPE: An FNCLCC phase II study with lapatinib (L) and capecitabine (C) in patients with brain metastases (BM) from HER2-positive (+) metastatic breast cancer (MBC) before whole-brain radiotherapy (WBR).
- (2017) T. D. Bachelot et al. JOURNAL OF CLINICAL ONCOLOGY
- Brain metastases: pathobiology and emerging targeted therapies
- (2012) Matthias Preusser et al. ACTA NEUROPATHOLOGICA
- Brain metastases free survival differs between breast cancer subtypes
- (2012) A Berghoff et al. BRITISH JOURNAL OF CANCER
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
- (2012) José Baselga et al. LANCET
- Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy
- (2012) R. Duchnowska et al. ONCOLOGIST
- Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery?
- (2012) D. Rades et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors
- (2012) C. Gani et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis
- (2011) Michal Mego et al. BREAST
- Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab
- (2011) Mafalda Oliveira et al. BREAST CANCER RESEARCH AND TREATMENT
- Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases
- (2011) R Bartsch et al. BRITISH JOURNAL OF CANCER
- Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis
- (2011) Dirk Rades et al. CANCER
- Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER
- (2011) A. M. Brufsky et al. CLINICAL CANCER RESEARCH
- Surgical treatment of brain metastasis: A review
- (2011) Melike Mut CLINICAL NEUROLOGY AND NEUROSURGERY
- Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases
- (2011) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
- (2011) Paul W. Sperduto et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases
- (2011) Nancy U. Lin et al. JOURNAL OF NEURO-ONCOLOGY
- Meningeal carcinomatosis in breast cancer: prognostic factors and outcome
- (2011) Carla Rameri Alexandre Silva de Azevedo et al. JOURNAL OF NEURO-ONCOLOGY
- P-Glycoprotein (ABCB1) Transports the Primary Active Tamoxifen Metabolites Endoxifen and 4-Hydroxytamoxifen and Restricts Their Brain Penetration
- (2011) D. Iusuf et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer
- (2011) Kunal S. Taskar et al. PHARMACEUTICAL RESEARCH
- Survival of breast cancer patients with meningeal carcinomatosis
- (2010) H. Gauthier et al. ANNALS OF ONCOLOGY
- Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine
- (2010) G. Metro et al. ANNALS OF ONCOLOGY
- Pazopanib Reveals a Role for Tumor Cell B-Raf in the Prevention of HER2+ Breast Cancer Brain Metastasis
- (2010) B. Gril et al. CLINICAL CANCER RESEARCH
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Preliminary Results of Whole Brain Radiotherapy With Concurrent Trastuzumab for Treatment of Brain Metastases in Breast Cancer Patients
- (2010) Cyrus Chargari et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Open-Label, Phase II, Multicenter, Randomized Study of the Efficacy and Safety of Two Dose Levels of Pertuzumab, a Human Epidermal Growth Factor Receptor 2 Dimerization Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer
- (2010) Kimberly L. Blackwell et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
- (2010) Martin Kocher et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
- (2010) Kevin C. De Braganca et al. JOURNAL OF NEURO-ONCOLOGY
- DEGRO Practical Guidelines for Palliative Radiotherapy of Breast Cancer Patients: Brain Metastases and Leptomeningeal Carcinomatosis
- (2010) Petra Feyer et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study
- (2009) S. Siena et al. ANNALS OF ONCOLOGY
- Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)
- (2009) A. Niwinska et al. ANNALS OF ONCOLOGY
- Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer
- (2009) Rupert Bartsch et al. BMC CANCER
- Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but notHER2/neu-positive breast cancer
- (2009) Kan Yonemori et al. CANCER
- Bevacizumab and Paclitaxel for Breast Cancer Patients with Central Nervous System Metastases: A Case Series
- (2009) Sana Intidhar Labidi et al. Clinical Breast Cancer
- Bevacizumab Safety in Patients with Central Nervous System Metastases
- (2009) B. Besse et al. CLINICAL CANCER RESEARCH
- Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
- (2009) N. U. Lin et al. CLINICAL CANCER RESEARCH
- Safety of Bevacizumab in Patients With Non–Small-Cell Lung Cancer and Brain Metastases
- (2009) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Real-time imaging reveals the single steps of brain metastasis formation
- (2009) Yvonne Kienast et al. NATURE MEDICINE
- Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report
- (2008) Hans-Joachim Stemmler et al. ANTI-CANCER DRUGS
- A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
- (2008) David Cameron et al. BREAST CANCER RESEARCH AND TREATMENT
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer
- (2008) Nancy U. Lin et al. CANCER
- Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab
- (2008) Mariantonietta Colozza et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Neoplastic Meningitis
- (2008) M. C. Chamberlain ONCOLOGIST
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started